GSK to buy US biotech firm IDRx for up to $1.15 billion
2 days ago · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …
reuters.com
OFF
GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion (1)
2 weeks from now
2 days ago · GSK Plc agreed to buy US biotech IDRx for as much as $1.15 billion to gain new cancer medicines.. The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for …
bloomberglaw.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion - U.S. News
2 weeks from now
2 days ago · (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …
usnews.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for …
indiatimes.com
OFF
GSK Nears $1bn Deal For Biotech Developing Drug For Rare Tumour
2 weeks from now
6 days ago · Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare …
ft.com
OFF
GSK Nears $1B Deal To Buy U.S. Biotech IDRx (GSK:NYSE)
2 weeks from now
6 days ago · British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The …
seekingalpha.com
OFF
GSK In Talks To Buy U.S. Rare Tumor Specialist IDRx For Up To $1 ...
2 weeks from now
6 days ago · --Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 …
morningstar.com
OFF
GSK Nears $1 Billion Deal For Biotech Company IDRx - MSN
2 weeks from now
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.
msn.com
OFF
GSK Plc Entered Into An Agreement To Acquire IDRX, Inc. For ...
2 weeks from now
2 days ago · GSK plc (LSE:GSK) entered into an agreement to acquire IDRX, Inc. for approximately $1.2 billion on January 13, 2025. Under the terms of the agreement, GSK will …
marketscreener.com
OFF
GSK Said To Be Nearing $1 Billion Deal For Biotech Company IDRx
2 weeks from now
6 days ago · GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology …
bloomberglaw.com
OFF
Is GSK Prepping A $1bn Takeover Bid For IDRx? | Pharmaphorum
2 weeks from now
6 days ago · GSK confirms that it has agreed to buy US biotech IDRx and its KIT inhibitor for rare gastrointestinal tumours for $1bn upfront. News Lilly nets Scorpion cancer drug in $2.5bn …
pharmaphorum.com
OFF
GSK Is Said To Be Nearing $1B Deal To Acquire U.S. Biotech IDRx
2 weeks from now
British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The Financial Times …
msn.com
OFF
GSK Nears $1B Deal To Acquire IDRx - Grafa.com
2 weeks from now
6 days ago · British pharmaceutical giant GSK is reportedly in advanced talks to acquire IDRx, a privately-held biotechnology company focused on developing treatments for a rare type of tumor. According to the Financial Times, citing sources close to the negotiations, the deal is valued at approximately $1 billion.
grafa.com
OFF
GSK Nearing Deal To Acquire US Biotech IDRx For Up To $1 Billion
2 weeks from now
6 days ago · -- GSK is in advanced discussions to acquire privately-owned US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …
marketscreener.com
OFF
GSK Nearing $1 Billion Deal To Acquire US Biotech IDRx, FT Reports
2 weeks from now
6 days ago · GSK Reportedly in Advanced Talks to Buy US Biotech IDRx Jan. 09: MT GSK in Talks to Buy U.S. Rare Tumor Specialist IDRx for up to $1 Billion, FT Says, Citing Sources …
marketscreener.com
OFF
GSK Swooping To Buy US Biotech IDRx For $1bn - Report
2 weeks from now
6 days ago · UK pharma giant GSK PLC is close to buying US biotech startup IDRx for $1 billion to boost its cancer drug business, the Financial Times has reported. ...
proactiveinvestors.co.uk
OFF
Recon: FTC Says PBMs Inflated Drug Prices To Generate $7.3B In …
2 weeks from now
1 day ago · Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
raps.org
FAQs about GSK to buy US biotech firm IDRx for up to $1.15 billion Coupon?
Does GSK buy idrx?
Could GSK & idrx opt out of a biotech deal?
How did GSK perform in the first three quarters of 2024?
Will GSK sell blenrep again?
Who owns idrx biotech?
Who owns idrx-42?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
